Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05191758 · ClinicalTrials.gov registry record · NA
Nutritional Regulation of Leukocyte Function
A NA study, sponsored by Indiana University.
- Completed
- Registry status
- NA
- Development phase
- 31
- Enrollment target
NCT05191758 is a NA study that has completed, run by Indiana University. The registered enrollment target is 31 participants.
The verdict
NCT05191758, a NA study, has completed, sponsored by Indiana University.
- COMPLETED
- Registry status
- NA
- Development phase
- 31 participants
- Enrollment target
Study Summary
The objective of the current study is to determine the dose at which Fermented Papaya Preparation ( FPP) is able to improve inducible respiratory burst outcomes in peripheral blood mononuclear cells (PBMC) and neutrophils of participants. Our investigators have reported that supplementation with standardized fermented papaya preparation (FPP) in mice improves dermal wound healing outcomes. Therefore, based on these observations, the investigators propose to study the dose at which FPP supplementation induces respiratory burst in blood-derived myeloid cells in healthy subjects.
Interventions
- DIETARY_SUPPLEMENT FPP supplement
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 31 participants |
| Start Date | 2022-02-15 |
| Est. Completion | 2023-07-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05191758
The ClinicalTrials.gov registry entry for NCT05191758 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 31 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Indiana University, which has 890 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which FPP supplement is the first listed.
NCT05191758 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05191758 about?
NCT05191758 is a clinical study titled "Nutritional Regulation of Leukocyte Function". The objective of the current study is to determine the dose at which Fermented Papaya Preparation ( FPP) is able to improve inducible respiratory burst outcomes in peripheral blood mononuclear cells (PBMC) and neutrophils of participants. Our investigators have reported that supplementation with sta...
What is the current status of trial NCT05191758?
This trial is currently completed. It is a NA study. The enrollment target is 31 participants. The study started on 2022-02-15. Estimated completion is 2023-07-31.
What interventions are being tested in trial NCT05191758?
The interventions under investigation include: FPP supplement (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT05191758?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.